Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekAJMC ↗
Balancing Cost, Utilization, and Risk in CLL Treatment: Adam Kittai, MD…
The WeekBioPharma Dive ↗
The setback dims the outlook for a medicine Pfizer sees as an important contributor going forward, though some…
The WeekPharmaVoice ↗
In interviews as well as a panel at BIO's annual meeting, investors and life sciences bankers predicted an acc…
The WeekPharmaVoice ↗
Aquestive's fast response to an FDA rejection reveals why some drugmakers are betting on domestic operations d…
The WeekFiercePharma ↗
Amid efforts in Germany to retool the country's drug spending, the U.S. is launching an investigation into wha…
The WeekFierceBiotech ↗
Exelixis' next franchise drug, zanzalintinib, has hit a clinical setback, although at least two groups of anal…
The WeekBriefing
China grants CARsgen approval for a Claudin18.2-targeted therapy, marking the first CAR-T authorized for solid…
The WeekDrug Channels ↗
By Adam J. Fein, Ph.D. and Greis Kapexhiu It's time for Drug Channels' annual look at pharmacist salaries and …
The WeekDrug Channels ↗
By Adam J. Fein, Ph.D. and Greis Kapexhiu It's time for Drug Channels' annual look at pharmacist salaries and …
The WeekSTAT News ↗
Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to a…
The WeekAJMC ↗
Social Factors May Match, Outpace Genetic Risk in Disease Prediction…
The WeekBioPharma Dive ↗
The agency took another step toward clearing a backlog of Makary-era rejections that appeared to contradict ea…
The WeekFiercePharma ↗
Pharma companies have been part of the global economy and health systems for centuries. Now, as drugmakers pla…
The WeekFierceBiotech ↗
Recently appointed Sanofi CEO Belén Garijo has stamped her mark on the organization, hiring Paulo Fontoura, M.…
The WeekBriefing
The move follows a June 8 deadline set for hospitals that failed to provide claims data required under Lilly’s…
The WeekBioPharma Dive ↗
Women's health audiences have long memories and finely tuned instincts for what is performative.…
The WeekSTAT News ↗
Health disparities researchers say a new White House proposal could disqualify much of their work from federal…
The WeekFiercePharma ↗
Name recognition and "familiarity" with Novo Nordisk's oral Wegovy has contributed to its rapid uptake in its …
The WeekFierceBiotech ↗
In another biotech born out of China's "NewCo" model, cAMPfield Therapeutics has launched with a $180 million …
The WeekBriefing
With pharma M&A and IPOs accelerating, unprepared companies risk missing out as investors demand speed, clean …
The WeekBriefing
The 4E deal extends Eli Lilly’s 2026 M&A streak and deepens its bet on novel, non-opioid pain treatments amid …
The WeekAJMC ↗
Hybrid, Outpatient, Network-Based: Bispecific Programs Take Shape Differently…
The WeekAJMC ↗
Chemo-Free Options Abound for Transplant-Ineligible MCL, Kumar Explains…
The WeekFiercePharma ↗
Pfizer's CFO Dave Denton will officially depart in August, leaving SVP of finance Cecile Guegan to take up his…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.